Status:
UNKNOWN
Sentinel Lymph Node Assessment in Ovarian Cancer (TRSGO-SLN-OO5)
Lead Sponsor:
Acibadem University
Conditions:
Ovarian Cancer
Sentinel Lymph Node
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The aim of the study to evaluate the feasibility and accuracy of sentinel lymph node technique in ovarian cancer.
Detailed Description
Systematic pelvic and paraaortic lymphadenectomy is commonly performed in ovarian cancer patients. However, in early ovarian cancer systematic lymphadenectomy can be an unnecessary procedure which can...
Eligibility Criteria
Inclusion
- Patients with Early stage ovarian cancer
Exclusion
- Patient who had been administrated chemotherapy prior to surgery
- Patients who had diagnosed with malignancy other than ovarian cancer.
- Patients who had undergone pelvic or paraaortic lymphadenectomy or surgery prior to surgery.
- Patients who have allergy for the tracers.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04714931
Start Date
January 1 2021
End Date
April 1 2022
Last Update
February 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Acibadem MAA University Maslak Hospital
Istanbul, Turkey (Türkiye), 34457